Newborn cystic fibrosis screening: influence of prematurity on the concentration of immunoreactive trypsinogen [IRT]

M. Montgomery, M. Stephenson, V. Lim, S. Menon, C. Larsen, H. Wilde, P. Bridge, M. Lyon (Calgary, AB, Canada)

Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session: Cystic fibrosis lung disease: what do we measure? What do we know?
Session type: Electronic Poster Discussion
Number: 339
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Montgomery, M. Stephenson, V. Lim, S. Menon, C. Larsen, H. Wilde, P. Bridge, M. Lyon (Calgary, AB, Canada). Newborn cystic fibrosis screening: influence of prematurity on the concentration of immunoreactive trypsinogen [IRT]. Eur Respir J 2007; 30: Suppl. 51, 339

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Newborn cystic fibrosis (CF) screening: influence of data transformation and density estimation on newborn recall
Source: Eur Respir J 2007; 30: Suppl. 51, 30s
Year: 2007

Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012


Infant pulmonary function - Raised Volume Technique
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006


Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011


Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM)
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010


Underestimation of lung clearance index values in infants with cystic fibrosis due to software analysis algorithms
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015

Normal lung function in infants with cystic fibrosis shortly after birth
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013

Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009


Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF)
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Should the D1152H variant be included in cystic fibrosis newborn screening programmes?
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Newborn screening for cystic fibrosis in Spain
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015